News

• Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
  04/20/2021 / 12:34 - GlobeNewswire
•  
• Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
  04/19/2021 / 10:00 - GlobeNewswire
•  
• Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
  04/09/2021 / 22:00 - GlobeNewswire
•  
• Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
  04/01/2021 / 12:45 - GlobeNewswire
•  
• Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
  03/31/2021 / 12:45 - GlobeNewswire
•  
• BioNTech Announces Full Year 2020 Financial Results and Corporate Update
  03/30/2021 / 12:30 - GlobeNewswire
•  
• Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis
  03/30/2021 / 07:21 - GlobeNewswire
•  
• BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site
  03/26/2021 / 14:45 - GlobeNewswire
•  
• EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
  03/26/2021 / 14:20 - GlobeNewswire
•  
• BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021
  03/23/2021 / 12:00 - GlobeNewswire
•  
• Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared
  03/11/2021 / 12:45 - GlobeNewswire
•  
• Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
  02/25/2021 / 20:53 - GlobeNewswire
•  
• Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
  02/25/2021 / 12:45 - GlobeNewswire
•  
• Genmab announces initiation of share buy-back program
  02/23/2021 / 17:05 - GlobeNewswire
•  
• Genmab Publishes 2020 Annual Report
  02/23/2021 / 17:00 - GlobeNewswire